Dataset Information

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.

ABSTRACT:

Introduction

Latinos living with HIV in the Americas share a common ethnic and cultural heritage. In North America, Latinos have a relatively high rate of new HIV infections but lower rates of engagement at all stages of the care continuum, whereas in Latin America antiretroviral therapy (ART) services continue to expand to meet treatment needs. In this analysis, we compare HIV treatment outcomes between Latinos receiving ART in North America versus Latin America.

Methods

HIV-positive adults initiating ART at Caribbean, Central and South America Network for HIV (CCASAnet) sites were compared to Latino patients (based on country of origin or ethnic identity) starting treatment at North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) sites in the United States and Canada between 2000 and 2011. Cox proportional hazards models compared mortality, treatment interruption, antiretroviral regimen change, virologic failure and loss to follow-up between cohorts.

Results

The study included 8400 CCASAnet and 2786 NA-ACCORD patients initiating ART. CCASAnet patients were younger (median 35 vs. 37 years), more likely to be female (27% vs. 20%) and had lower nadir CD4 count (median 148 vs. 195 cells/µL, p<0.001 for all). In multivariable analyses, CCASAnet patients had a higher risk of mortality after ART initiation (adjusted hazard ratio (AHR) 1.61; 95% confidence interval (CI): 1.32 to 1.96), particularly during the first year, but a lower hazard of treatment interruption (AHR: 0.46; 95% CI: 0.42 to 0.50), change to second-line ART (AHR: 0.56; 95% CI: 0.51 to 0.62) and virologic failure (AHR: 0.52; 95% CI: 0.48 to 0.57).

Conclusions

HIV-positive Latinos initiating ART in Latin America have greater continuity of treatment but are at higher risk of death than Latinos in North America. Factors underlying these differences, such as HIV testing, linkage and access to care, warrant further investigation.

SUBMITTER: Cesar C

PROVIDER: S-EPMC4800379 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.

Cesar Carina C Koethe John R JR Giganti Mark J MJ Rebeiro Peter P Althoff Keri N KN Napravnik Sonia S Mayor Angel A Grinsztejn Beatriz B Wolff Marcelo M Padgett Denis D Sierra-Madero Juan J Gotuzzo Eduardo E Sterling Timothy R TR Willig James J Levison Julie J Kitahata Mari M Rodriguez-Barradas Maria C MC Moore Richard D RD McGowan Catherine C Shepherd Bryan E BE Cahn Pedro P

Journal of the International AIDS Society 20160318 1

<h4>Introduction</h4>Latinos living with HIV in the Americas share a common ethnic and cultural heritage. In North America, Latinos have a relatively high rate of new HIV infections but lower rates of engagement at all stages of the care continuum, whereas in Latin America antiretroviral therapy (ART) services continue to expand to meet treatment needs. In this analysis, we compare HIV treatment outcomes between Latinos receiving ART in North America versus Latin America.<h4>Methods</h4>HIV-posi ...[more]

PMID: 26996992

Similar Datasets

Project description:BackgroundHigh early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Africa, compared to Europe and North America, is well documented. Longer-term comparisons between settings have been limited by poor ascertainment of mortality in high burden African settings. This study aimed to compare mortality up to four years on ART between South Africa, Europe, and North America.Methods and findingsData from four South African cohorts in which patients lost to follow-up (LTF) could be linked to the national population register to determine vital status were combined with data from Europe and North America. Cumulative mortality, crude and adjusted (for characteristics at ART initiation) mortality rate ratios (relative to South Africa), and predicted mortality rates were described by region at 0-3, 3-6, 6-12, 12-24, and 24-48 months on ART for the period 2001-2010. Of the adults included (30,467 [South Africa], 29,727 [Europe], and 7,160 [North America]), 20,306 (67%), 9,961 (34%), and 824 (12%) were women. Patients began treatment with markedly more advanced disease in South Africa (median CD4 count 102, 213, and 172 cells/µl in South Africa, Europe, and North America, respectively). High early mortality after starting ART in South Africa occurred mainly in patients starting ART with CD4 count <50 cells/µl. Cumulative mortality at 4 years was 16.6%, 4.7%, and 15.3% in South Africa, Europe, and North America, respectively. Mortality was initially much lower in Europe and North America than South Africa, but the differences were reduced or reversed (North America) at longer durations on ART (adjusted rate ratios 0.46, 95% CI 0.37-0.58, and 1.62, 95% CI 1.27-2.05 between 24 and 48 months on ART comparing Europe and North America to South Africa). While bias due to under-ascertainment of mortality was minimised through death registry linkage, residual bias could still be present due to differing approaches to and frequency of linkage.ConclusionsAfter accounting for under-ascertainment of mortality, with increasing duration on ART, the mortality rate on HIV treatment in South Africa declines to levels comparable to or below those described in participating North American cohorts, while substantially narrowing the differential with the European cohorts. Please see later in the article for the Editors' Summary.

Project description:Cardiovascular disease and non-AIDS malignancies have become major causes of death among HIV-infected individuals. The relative impact of lifestyle and HIV-related factors are debated.We estimated associations of smoking with mortality more than 1 year after antiretroviral therapy (ART) initiation among HIV-infected individuals enrolled in European and North American cohorts. IDUs were excluded. Causes of death were assigned using standardized procedures. We used abridged life tables to estimate life expectancies. Life-years lost to HIV were estimated by comparison with the French background population.Among 17,995 HIV-infected individuals followed for 79,760 person-years, the proportion of smokers was 60%. The mortality rate ratio (MRR) comparing smokers with nonsmokers was 1.94 [95% confidence interval (95% CI) 1.56-2.41]. The MRRs comparing current and previous smokers with never smokers were 1.70 (95% CI 1.23-2.34) and 0.92 (95% CI 0.64-1.34), respectively. Smokers had substantially higher mortality from cardiovascular disease, non-AIDS malignancies than nonsmokers [MRR 6.28 (95% CI 2.19-18.0) and 3.31 (95% CI 1.80-5.45), respectively]. [corrected]. Among 35-year-old HIV-infected men, the loss of life-years associated with smoking and HIV was 7.9 (95% CI 7.1-8.7) and 5.9 (95% CI 4.9-6.9), respectively. The life expectancy of virally suppressed, never-smokers was 43.5 years (95% CI 41.7-45.3), compared with 44.4 years among 35-year-old men in the background population. Excess MRRs/1000 person-years associated with smoking increased from 0.6 (95% CI -1.3 to 2.6) at age 35 to 43.6 (95% CI 37.9-49.3) at age at least 65 years.Well treated HIV-infected individuals may lose more life years through smoking than through HIV. Excess mortality associated with smoking increases markedly with age. Therefore, increases in smoking-related mortality can be expected as the treated HIV-infected population ages. Interventions for smoking cessation should be prioritized.

Project description:Global metrics of land cover and land use provide a fundamental basis to examine the spatial variability of human-induced impacts on freshwater ecosystems. However, microscale processes and site specific conditions related to bank vegetation, pollution sources, adjacent land use and water uses can have important influences on ecosystem conditions, in particular in smaller tributary rivers. Compared to larger order rivers, these low-order streams and rivers are more numerous, yet often under-monitored. The present study explored the relationship of nutrient concentrations in 150 streams in 57 hydrological basins in South, Central and North America (Buenos Aires, Curitiba, São Paulo, Rio de Janeiro, Mexico City and Vancouver) with macroscale information available from global datasets and microscale data acquired by trained citizen scientists. Average sub-basin phosphate (P-PO4) concentrations were found to be well correlated with sub-basin attributes on both macro and microscales, while the relationships between sub-basin attributes and nitrate (N-NO3) concentrations were limited. A phosphate threshold for eutrophic conditions (>0.1 mg L-1 P-PO4) was exceeded in basins where microscale point source discharge points (eg. residential, industrial, urban/road) were identified in more than 86% of stream reaches monitored by citizen scientists. The presence of bankside vegetation covaried (rho = -0.53) with lower phosphate concentrations in the ecosystems studied. Macroscale information on nutrient loading allowed for a strong separation between basins with and without eutrophic conditions. Most importantly, the combination of macroscale and microscale information acquired increased our ability to explain sub-basin variability of P-PO4 concentrations. The identification of microscale point sources and bank vegetation conditions by citizen scientists provided important information that local authorities could use to improve their management of lower order river ecosystems.

Dataset Information

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.

Introduction

Methods

Results

Conclusions

Publications

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets